Wall Street is positive on Alaunos Therapeutics Inc (TCRT). On average, analysts give Alaunos Therapeutics Inc a Hold rating. The average price target is $2.998, which means analysts expect the stock to climb by 74.30% over the next twelve months.
That average ranking earns Alaunos Therapeutics Inc an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating TCRT a Hold today. Find out what this means to you and get the rest of the rankings on TCRT!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Alaunos Therapeutics Inc Stock Today?
Alaunos Therapeutics Inc (TCRT) stock is up 4.88% while the S&P 500 has fallen -0.57% as of 10:20 AM on Friday, Mar 15. TCRT is higher by $0.08 from the previous closing price of $1.64 on volume of 8,256 shares. Over the past year the S&P 500 has risen 29.31% while TCRT has fallen -76.82%. TCRT lost -$2.32 per share the over the last 12 months.
Click Here to get the full Stock Report for Alaunos Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
